Please provide your email address to receive an email when new articles are posted on . Researchers reviewed the efficacy of ravulizumab based on 2-year data from two phase 3, single-arm studies. eGFR ...

The MarketWatch News Department was not involved in the creation of this content. -- Real-World Implementation: Proenkephalin A 119-159 (penKid) has been successfully integrated into daily practice in ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce albuminuria (excess albumin in the urine) and the risk of chronic kidney disease (CKD) progression, and certain mineralocorticoid receptor ...

A face-off between two experimental treatments for a common kidney disease is sending shares of the biotech Vera Therapeutics on a wild ride. Vera, based in Brisbane, Calif., unveiled data Monday that ...

March 10 (Reuters) - La Jolla Pharmaceutical Co said its lead experimental drug to treat chronic kidney disease met the main goal of improving kidney function in a mid-stage study, sending the company ...

Most people turn to fruits whenever they want to improve their health. The kidneys are, however, in need of some specific fruits to remain in proper shape. Your kidneys do so much work in regulating ...

Over 100 million Americans currently live with high blood pressure, yet many remain unaware of its profound connection to kidney health. This relationship represents one of medicine’s most critical ...

Investing.com -- Shares of Innovate Corp. (NYSE:VATE) surged 60% following the announcement that the U.S. Food and Drug Administration (FDA) has approved the company's MediBeacon Transdermal GFR ...

Real-World Implementation: Proenkephalin A 119-159 (penKid) has been successfully integrated into daily practice in intensive care unit (ICU), demonstrating its effectiveness in assessing kidney ...